Cancers, UTIs (urinary tract infections) and AF (atrial fibrillation) feature in hefty new NICE (UK National Institute for Clinical Excellence) agenda
This article was originally published in Clinica
Executive Summary
Thrombophilia screening and the diagnosis and management of cancers, urinary tract infections (UTIs) and atrial fibrillation (AF) are among the ten technologies and seven areas of clinical practice that the UK's National Institute for Clinical Excellence (NICE) has been commissioned by the Department of Health to undertake under its ninth work programme.
You may also be interested in...
Sanofi Clinches Key Phase III Immunology Win With Rilzabrutinib
Sanofi’s BTK inhibitor – one of two from its 2021 Principia buy – passed a Phase III test in immune thrombocytopenia as the company focuses on Dupixent-like blockbusters going forward.
US FDA Gene Therapy Accelerated Approval Guidance Will Describe ‘Buckets’ Of Use Scenarios
Forthcoming guidance is expected to describe areas of “low-hanging fruit” and those that are more challenging for use of the expedited pathway, Center for Biologics Evaluation and Research Director Peter Marks said.
FTC Early Findings In PBM Investigation Coming By Mid-Summer, Chair Kahn Says
The agency is also poised to announce another development in its scrutiny of the drug patents listed in the FDA’s Orange Book.